تقرير
Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients.
العنوان: | Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients. |
---|---|
المؤلفون: | Balandín B; Department of Critical Care Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Electronic address: balandinmoreno@gmail.com., Pintado V; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain., Pérez-Pedrero MJ; Department of Critical Care Medicine, Hospital Universitario de Toledo, Toledo, Spain., Martínez-Sagasti F; Department of Critical Care Medicine, Hospital Universitario Clínico San Carlos, Madrid, Spain., Sancho-González M; Department of Critical Care Medicine, Hospital Universitario Gregorio Marañón, Madrid, Spain., Soriano-Cuesta C; Department of Critical Care Medicine, Hospital Universitario Ramón y Cajal, Madrid, Spain., Gesso CM; Department of Critical Care Medicine, Hospital Universitario del Sudeste, Madrid, Spain., Chicot M; Department of Critical Care Medicine, Hospital Universitario de La Princesa, Madrid, Spain., de Luna RR; Department of Critical Care Medicine, Hospital Universitario Fundación de Alcorcón, Madrid, Spain., Asensio-Martín MJ; Department of Critical Care Medicine, Hospital Universitario La Paz, Madrid, Spain., Catalan M; Department of Critical Care Medicine, Hospital Universitario Doce de Octubre, Madrid, Spain., Díaz-Díaz JJ; Department of Critical Care Medicine, Hospital Universitario de Gran Canaria Doctor Negrín; Gran Canaria, Spain., Carbonell N; Department of Critical Care Medicine, Hospital Clínico Universitario de Valencia., Iranzo R; Department of Anesthesiology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Royuela A; Clinical Biostatistics, Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, Madrid, Spain., Ballesteros D; Department of Critical Care Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. |
المصدر: | International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 May; Vol. 63 (5), pp. 107121. Date of Electronic Publication: 2024 Feb 24. |
نوع المنشور: | Letter; Multicenter Study |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Amsterdam : Elsevier Science Publishers, c1991- |
مواضيع طبية MeSH: | Critical Illness* , Anti-Bacterial Agents*/therapeutic use , Cefiderocol* , Cephalosporins*/therapeutic use , Gram-Negative Bacterial Infections*/drug therapy , Gram-Negative Bacterial Infections*/microbiology, Humans ; Male ; Middle Aged ; Aged ; Female ; Gram-Negative Bacteria/drug effects ; Treatment Outcome |
المشرفين على المادة: | 0 (Anti-Bacterial Agents) SZ34OMG6E8 (Cefiderocol) 0 (Cephalosporins) |
تواريخ الأحداث: | Date Created: 20240226 Date Completed: 20240430 Latest Revision: 20240516 |
رمز التحديث: | 20240516 |
DOI: | 10.1016/j.ijantimicag.2024.107121 |
PMID: | 38408494 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1872-7913 |
---|---|
DOI: | 10.1016/j.ijantimicag.2024.107121 |